AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
Scientific Papers found: Click to Expand⟱
*antiOx↑, *Inflam↓, Risk↓, AntiCan∅, Apoptosis↑, ROS↓, NRF2↓, Akt↓, ERK↓, NF-kB↓, Bcl-2↓, BAX↑, Casp3↑, DNAdam↑, ROS↓, P53↑, PCNA↓, cycD1/CCND1↓, TumCP↓, Hif1a↓, NOTCH↓, miR-590-3p↑, TumCMig↓, TumCI↓, TumMeta↓, TumCA↓, *BioAv↓,
IL2↑, INF-γ↑, Th1 response↑, Th2↑, Dose↑, AntiCan∅, Risk↑, chemoP↑, Hif1a↓, VEGF↓, selectivity↑, *GADD45A↑, NRF2↓, *NRF2↑, ChemoSen↑, angioG↓, PrxI↓, ChemoSideEff↓, eff↑,
eff∅, AntiCan∅,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
miR-590-3p↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
NRF2↓, 2, PrxI↓, 1, ROS↓, 2,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, Casp3↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, PCNA↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ERK↓, 1, NOTCH↓, 1,
Migration(tgid=13) ⓘ
TumCA↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, Hif1a↓, 2, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL2↑, 1, INF-γ↑, 1, NF-kB↓, 1, Th1 response↑, 1, Th2↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↑, 1, eff↑, 1, eff∅, 1, selectivity↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan∅, 3, chemoP↑, 1, ChemoSideEff↓, 1, Risk↓, 1, Risk↑, 1,
Total Targets: 38
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, NRF2↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
GADD45A↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1,
Total Targets: 5
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:813 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page